Search, analyze & compare
My selected companies
Adjust valuation method
![]()
Detail of Calithera Biosciences Inc
CEO
Dr. Susan M. Molineaux Ph.D.
Employees
8
Industry
Biotechnology
Sector
Healthcare
Market cap
$16,541
Company details
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Stock vs Industry average
-
Industry average
Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$8.15
Margin profit
0.00%
52 week low
$0.0001
52 week high
$0.05
50-day simple moving average
$0.00
200-day simple moving average
$0.01
Percent held by insiders
1.07%
Percent held by institutions
0.00%
Dividend yield
(not set)
